Drug safety firm BioSoteria, Inc. honored Dr. Hugh H. Tilson with the first PDSS Leadership Award at the 3rd Annual Pacific Drug Safety Summit, which took place last Friday in San Francisco. Dr. Tilson, an internationally acclaimed epidemiologist and outcomes researcher, was the moderator of the event and serves as Chairman of BioSoteria's Board of Advisors.
Emeryville, CA (PRWEB) September 30, 2009 -- BioSoteria, Inc., a drug safety services and training firm, honored Hugh H. Tilson, MD, DrPH, with the first PDSS Leadership Award at the 3rd Annual Pacific Drug Safety Summit, which took place last Friday in San Francisco. Dr. Tilson was the moderator of the event and serves as Chairman of BioSoteria's Board of Advisors.
The award was presented by Sally Van Doren, PharmD, President and Chief Executive Officer of BioSoteria, the conference organizer. In her comments to an audience of nearly 130 drug safety practitioners and providers, Dr. Van Doren remarked, "Hugh's thoughtful, candid and lively participation as keynote speaker and moderator at the three Pacific Drug Safety Summits has contributed to the annual event's unprecedented success."
Upon receiving the award, Dr. Tilson said, "I am especially honored by the words inscribed: 'Living the Vision.' Improving public health is my life's work, and I am pleased to support the vision of PDSS to educate drug safety professionals and create a forum for exchange of best pharmacovigilance practices."
About Hugh H. Tilson, MD, Dr.P.H., FISPE
An internationally acclaimed epidemiologist and outcomes researcher, Dr. Tilson's career in public health and preventive medicine spans forty years. He spent fifteen years in public service, including duties as a U.S. Army Preventive Medicine Off
Copyright©2009 Vocus, Inc.
All rights reserved